RSS
Principia Biopharma
Sanofi and Principia join forces to advance potential MS therapy
Sanofi and Principia Biopharma have entered into an agreement to develop a clinical-stage oral drug candidate as a potential therapy for multiple sclerosis (MS) and other central nervous system (CNS) diseases. more